Researchers' Work from Xianyang Central Hospital Focuses on Combination Therapy (Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy).

Numerous clinical trials have incorporated SBRT into immunotherapy for advanced NSCLC, revealing that this combination therapy effectively inhibits local tumour growth while simultaneously activating systemic antitumour immune responses. Keywords: Clinical Research; Clinical Trials and Studies; Combination Therapy; Drugs and Therapies; Health and Medicine; Immunology; Immunotherapy; Pharmaceuticals EN Clinical Research Clinical Trials and Studies Combination Therapy Drugs and Therapies Health and Medicine Immunology Immunotherapy Pharmaceuticals 1504 1504 1 08/21/23 20230822 NES 230822 2023 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on combination therapy are presented in a new report. [Extracted from the article]